Clinical research received a boost on Friday as a syndicate of investors came together to put money into a
PercipEnz is a computer software company that develops and markets specialized, enterprise-class clinical research and biospecimen management systems. The PercipEnz flagship product, the Oncore® software platform, is intended to help research institutions increase their operational efficiency.
Government regulations can impose a significant compliance burden on scientific researchers. Although government regulations are meant to increase the integrity of scientific research data and thus increase the value of the results, compliance is not trivial, and there has been an increasing need for products that can reduce administrative headaches.
The Oncore platform helps researchers:
1) administer their portfolio of clinical trials
2) comply with government regulations
3) streamline research operations and
4) reduce duplication of effort with laboratory and hospital information system integration
“We have always taken a collaborative approach to satisfying the needs of research centers by actively involving them in the product development process,” says Dr. Tony O’Hare, chief scientific officer at PercipEnz. “That’s our ‘innovating through collaboration’ philosophy.” Through monthly teleconferences, quarterly newsletters, collaborative development initiatives, a community website, and semi-annual conferences, Oncore users receive the benefits of networking and training while they provide input into Oncore’s evolution.
The Oncore community, known as “Onsemble” convenes for their next face-to-face gathering, the Onsemble 2007 Fall Conference, on September 19-21 at
Over 20 research organizations have adopted Oncore to manage their entire portfolio of clinical trials.
Expressing his appreciation for this new investment,
NEW Capital Fund, LP, a venture capital firm headquartered in
NEW Capital Management, Inc. was joined in this investment by members of Wisconsin Investment Partners and Silicon Pastures.
“The company has achieved significant market traction. We were excited to see just how well their customers are responding to the Oncore product,” said Teresa Esser, managing director of Silicon Pastures LLC.
PercipEnz Technologies, Inc. is located at 708 Heartland Trail,
NEW Capital Fund L.P. Is managed by NEW Capital Management, Inc., which is located at
Wisconsin Investment Partners representative
Silicon Pastures’ managing director, Teresa Esser, can be reached at: 414-771-4350. E-mail: [email protected]. Website: www.siliconpastures.com.